TORONTO, ON / ACCESS Newswire / March 14, 2025 /abrdn Asia-Pacific Income Fund VCC (TSX:FAP) (UEN: T21VC0235H) (the "Company" ...
Receiving the FDA’s clearance to proceed with our Phase 2 clinical trial for TPST-1495, our second clinical program, in FAP marks an important step forward in developing new treatment options for ...
Biodexa Pharmaceuticals (BDRX) announced the results of its Type C meeting with the U.S. Food and Drug Administration, FDA, regarding the ...
A recent study has shed new light on the role of fibro-adipogenic progenitors (FAPs) in muscle regeneration, fibrosis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results